ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
12K |
3.9M |
112 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
12K
|
3.9M
|
112
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
12K |
3.9M |
108 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
12K
|
3.9M
|
108
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
otherperspective
|
1.0K |
453K |
126 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
1.0K
|
453K
|
126
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
otherperspective
|
245 |
98K |
98 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
245
|
98K
|
98
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
otherperspective
|
1.3K |
432K |
54 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.3K
|
432K
|
54
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
otherperspective
|
1.3K |
432K |
64 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.3K
|
432K
|
64
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
otherperspective
|
943 |
417K |
112 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
943
|
417K
|
112
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
otherperspective
|
274 |
112K |
49 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
274
|
112K
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
otherperspective
|
154 |
52K |
49 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
52K
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
otherperspective
|
549 |
190K |
64 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
190K
|
64
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
otherperspective
|
549 |
190K |
84 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
190K
|
84
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Financial Results Presentation
|
|
otherperspective
|
78 |
27K |
77 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
78
|
27K
|
77
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
12K |
3.9M |
82 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
12K
|
3.9M
|
82
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
12K |
3.9M |
63 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
12K
|
3.9M
|
63
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
12K |
3.9M |
59 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
12K
|
3.9M
|
59
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
otherperspective
|
574 |
204K |
104 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
204K
|
104
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
otherperspective
|
3.4K |
1.2M |
55 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
55
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
otherperspective
|
3.4K |
1.2M |
98 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
98
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
18K |
7.1M |
128 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
18K
|
7.1M
|
128
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Private Placement
|
|
otherperspective
|
71 |
38K |
115 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
71
|
38K
|
115
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection
|
|
otherperspective
|
275 |
115K |
114 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
275
|
115K
|
114
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
otherperspective
|
1.0K |
401K |
65 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
1.0K
|
401K
|
65
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Second Quarter Results Presentation
|
|
otherperspective
|
117 |
31K |
51 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
117
|
31K
|
51
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
otherperspective
|
914 |
301K |
75 |
20/02/23 |
20/02/23 |
ASX - By Stock
|
914
|
301K
|
75
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
otherperspective
|
914 |
301K |
72 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
914
|
301K
|
72
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
otherperspective
|
116 |
37K |
70 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
116
|
37K
|
70
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
12K |
3.9M |
75 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
12K
|
3.9M
|
75
|
|
ASX - By Stock
|
MSB |
Re:
MSB - All time biggest rebound thread
|
|
otherperspective
|
96 |
35K |
83 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
96
|
35K
|
83
|
|
ASX - By Stock
|
MSB |
Re:
Chronic Lower Back Pain - the sleeping giant.
|
|
otherperspective
|
484 |
151K |
84 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
484
|
151K
|
84
|
|
ASX - By Stock
|
MSB |
Re:
Chronic Lower Back Pain - the sleeping giant.
|
|
otherperspective
|
484 |
151K |
55 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
484
|
151K
|
55
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Litigation Update
|
|
otherperspective
|
82 |
25K |
64 |
19/05/22 |
19/05/22 |
ASX - By Stock
|
82
|
25K
|
64
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
otherperspective
|
151 |
41K |
43 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
151
|
41K
|
43
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Presents at Edison Group Global Healthcare Conference
|
|
otherperspective
|
267 |
66K |
66 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
267
|
66K
|
66
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
otherperspective
|
880 |
220K |
76 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
880
|
220K
|
76
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain
|
|
otherperspective
|
373 |
90K |
74 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
373
|
90K
|
74
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
otherperspective
|
880 |
220K |
48 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
880
|
220K
|
48
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
18K |
7.1M |
53 |
30/12/21 |
30/12/21 |
ASX - By Stock
|
18K
|
7.1M
|
53
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
otherperspective
|
6.0K |
3.0M |
62 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
6.0K
|
3.0M
|
62
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
18K |
7.1M |
101 |
19/09/21 |
19/09/21 |
ASX - By Stock
|
18K
|
7.1M
|
101
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
18K |
7.1M |
53 |
18/09/21 |
18/09/21 |
ASX - By Stock
|
18K
|
7.1M
|
53
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
otherperspective
|
6.0K |
3.0M |
107 |
10/09/21 |
10/09/21 |
ASX - By Stock
|
6.0K
|
3.0M
|
107
|
|
ASX - By Stock
|
MSB |
Re:
Disclosure issues
|
|
otherperspective
|
101 |
27K |
69 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
101
|
27K
|
69
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
otherperspective
|
763 |
329K |
38 |
12/01/21 |
12/01/21 |
ASX - By Stock
|
763
|
329K
|
38
|
|
ASX - By Stock
|
MSB |
Re:
USD573M in retained losses and a less than great 2020!. 2021 a year that cannot get worse
|
|
otherperspective
|
311 |
93K |
59 |
05/01/21 |
05/01/21 |
ASX - By Stock
|
311
|
93K
|
59
|
|
ASX - By Stock
|
MSB |
Re:
Do you still think Mesoblast will be the next CSL?
|
|
otherperspective
|
155 |
67K |
53 |
31/12/20 |
31/12/20 |
ASX - By Stock
|
155
|
67K
|
53
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
otherperspective
|
572 |
255K |
222 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
572
|
255K
|
222
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
otherperspective
|
13K |
5.0M |
104 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
104
|
|
ASX - By Stock
|
MSB |
Re:
IRENE KRISTAL, I, Plaintiff, v. MESOBLAST LIMITED, SILVIU ITESCU, and JOSH MUNTNER, Defendants.
|
|
otherperspective
|
223 |
100K |
92 |
10/10/20 |
10/10/20 |
ASX - By Stock
|
223
|
100K
|
92
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
otherperspective
|
23K |
13M |
199 |
14/07/20 |
14/07/20 |
ASX - By Stock
|
23K
|
13M
|
199
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
otherperspective
|
23K |
13M |
109 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
23K
|
13M
|
109
|
|